Table 1. Clinicopatholgical characteristics and CXCR4 status.
| CXCR4-negative (n=53) | CXCR4-positive (n=44) | P | |
|---|---|---|---|
| Age | 0.092 | ||
| ≤60/>60 | 24/29 | 12/32 | |
| Gender | 1.000 | ||
| Male/female | 20/33 | 17/27 | |
| Liver recurrence | 0.063 | ||
| No/yes | 35/18 | 20/24 | |
| Tumor size (cm) | 0.005 | ||
| 0–2/>2 | 14/39 | 2/42 | |
| Tumor extent | 0.363 | ||
| pT1 | 1 | 0 | |
| pT2 | 6 | 2 | |
| pT3 | 46 | 42 | |
| Lymph node metastasis | 0.012 | ||
| pN0/pN1 | 28/25 | 11/33 | |
| TNM stage | 0.029 | ||
| 1a | 1 | 0 | |
| 1b | 4 | 1 | |
| 2a | 23 | 10 | |
| 2b | 25 | 33 | |
| Pathologic grade | 0.952 | ||
| Well | 10 | 7 | |
| Moderate | 35 | 31 | |
| Poor | 8 | 6 | |
| Lymphovascular invasion | 0.093 | ||
| No/yes | 26/27 | 13/31 | |
| Perineural invasion | 0.816 | ||
| No/yes | 14/39 | 10/34 | |
| Adjuvant chemotherapy | 0.792 | ||
| No/yes | 43/10 | 37/7 |
TNM, tumor–node–metastasis.